DEF 14A

Company

Lexaria Bioscience Corp.

Filed

March 22, 2013

Period of Report

April 17, 2013

Accession Number

0001062993-13-001339

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →